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Abstract 
Background: The assessment of patients’ needs for care is a critical step in achieving 
patient-centred cancer care. Tools can be used to assess needs and inform care planning. The 
Needs Assessment Tool: Progressive Disease- Cancer (NAT: PD-C) is an Australian 
oncology clinic tool for assessment by clinicians of patients’ and carers’ palliative care needs. 
This has not been validated in the UK Primary Care setting.  
Aim: To test the psychometric properties and acceptability of a UK primary-care adapted 
NAT:PD-C.  
Design: Reliability: NAT: PD-C -guided video-recorded consultations were viewed, rated 
and re-rated by clinicians. Weighted Fleiss’ kappa and PABAK statistics were used. 
Construct: During a consultation GPs used NAT:PD-C, patient measures (Edmonton 
Symptom Assessment Scale; Research Utilisation Group Activities of Daily Living; 
Palliative care Outcome Score; Australian Karnofsky Performance Scale) and carer measures 
(Carer Strain Index; Carer Support Needs Assessment Tool).  Kendall’s Tau-b was used.  
Setting/Participants: General medical practitioners (GPs), nurses, patients and carers were 
recruited from primary care practices. 
Results: Reliability: All patient wellbeing items and 4/5 items in the carer/family ability to 
care section showed adequate inter-rater reliability. There was moderate test-retest reliability 
for 5/6 in the patient wellbeing section and 5/5 in the carer/family ability to care section. 
Construct: There was at least fair agreement for 5/6 of patient wellbeing items; high for daily 
living (Kendall’s Tau-b =0.57, p<0.001). The NAT:PD-C has adequate carer construct 
validity (5/8) with strong agreement for 2/8. Over three-quarters of GPs considered the NAT: 
PD-C to have high acceptability.  
Conclusion: The NAT PD-C is reliable, valid and acceptable the UK primary care setting. 
Effectiveness in reducing patient and carer unmet need and issues regarding implementation 
are yet to be evaluated.  
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Introduction 
The World Health Assembly has called for improved access to palliative care as a core 
component of health systems, emphasising primary and community/home-based care.1 
National Palliative and End of Life Care Partnership2 outlined the need for systematic ways 
of reaching those with advanced disease, effective assessment and decision making, care 
coordination, planning and delivery.  
A systematic review of cancer patient needs assessments commissioned by the Cancer Action 
Team, UK,3 defines a needs assessment tool as that which provides a consistent and 
comprehensive system to prompt discussion of a patients’ range of support and care needs; 
helps professionals triage tailored action and is useful for audit and service planning.3-5  
Despite a number of Needs Assessment Tools3, 6 available for people with cancer, few are 
designed for use by clinicians to identify and triage of palliative care needs of cancer patients 
in the busy clinical setting. Structured tools can reduce inequalities as they prompt discussion 
between patients, families and clinicians, provide a strategy for triaging people according to 
need, prioritise resources and identify areas for improvement.7   
The Needs Assessment Tool – Progressive Disease Cancer (NAT: PD-C) is an Australian 
one-page psychometrically valid, reliable and clinically acceptable clinician-completed tool 
for assessment of patients’ and carers’ palliative care needs across a range of domains in the 
oncology clinic.4, 7-9 The NAT:PD-C has four sections to prompt clinicians to assess holistic 
needs: priority prompts for specialised palliative care (3 items), patient well-being (6 items), 
ability of the carer/family to care for the patient (5 items), and carer well-being (2 items). The 
completed tool provides a profile of documented concerns matched with planned actions 
(“directly managed”, “refer to other team member”, “refer to specialist palliative care”) and 
may act as a referral form.  Therefore the tool differentiates between need that can be 
addressed by the usual care team and that which requires referral for specialist palliative care.  
As NAT: PD-C was developed and validated in Australia, its transferability to the UK cannot 
be assumed, and although primary care practitioners were involved in content validity testing 
it has not been formally tested in primary care.8 We therefore have adapted and tested the 
psychometric properties of the NAT:PD-C in UK primary care. This paper presents the inter-
rater and test-retest reliability, construct validity and acceptability of the NAT: PD-C in this 
setting. 
 
  
Methods 
Modification of the instrument 
Items and prompts of the original tool were revised using current literature relating to 
supportive and palliative needs of cancer patients and carers as appropriate to the UK social 
and cultural context.  An expert group, consisting of the research team, patient and carer 
representatives, and primary health care staff (doctors, practice nurses, district nurses, 
community palliative care nurse specialists), reviewed each aspect of the adapted NAT: PD-C 
for content and relevance for UK practice.  
Procedures 
Clinicians (general medical practitioners [GPs] and nurses), patients and family carers were 
recruited from primary care practices in North and East Yorkshire and Humber, England. 
Participants could contribute to either reliability or construct testing or both. Palliative care 
clinical nurse specialists were excluded. Eligible patients were consenting adults with a 
confirmed diagnosis of incurable cancer and able to complete study measures. Patients 
undergoing palliative chemotherapy, radiotherapy or other cancer treatments were eligible. 
Family carer participants were those identified by the patients who were willing to 
participate. Clinician training to use the NAT:PD-C comprised a brief (10-15 minute) 
explanation of the tool and how to use it in a clinical consultation by a member of the 
research team. 
Measures 
Measurement of the extent to which clinicians assign the same score to the same item is 
called inter-rater reliability. Nine video-recorded NAT:PD-C  guided clinical consultations 
were made by two GPs trained to use the NAT:PD-C, one from each of two practices. This 
allowed presentation of identical clinical information on multiple occasions to multiple raters 
without adding to participant burden.  Some consultations were conducted at the patient’s 
home and other in the surgery. A range of tumour types and stages were represented and 
some had family carers present.  
Participating clinicians individually rated at least one video-consultation for patient and carer 
needs using the NAT:PD-C. Videos were viewed and rated, either in groups or one-to-one 
facilitated by a researcher, or by accessing the video through a secure online service. For the 
test-retest reliability, clinicians were invited to re-rate the same video at least two weeks later. 
This method is one of the simplest ways of testing the stability and reliability of an 
instrument over time. 
Construct validity refers to how well a test or tool measures the construct that it was designed 
to measure. In this paper we have explored how well the NAT: PD-C items correlate with 
other previously validated questionnaires that measure the same construct (convergent 
validity).   Clinicians conducted a NAT:PD-C guided single clinic consultation with a 
participating patient and carer (if present). Consultations could be held in the surgery or 
patient’s home according to need and preference. Clinicians were encouraged to conduct the 
consultation as usual but to refer to the tool as an “aide-memoire”.  
After the consultation patients completed the Edmonton Symptom Assessment Scale (ESAS) 
(a patient-reported tool with a 0-10 numerical rating scale for the assessment of ten common 
symptoms),10 Research Utilisation Group Activities of Daily Living (RUG-ADL)11 (a 4-item 
clinician/researcher completed scale measuring four activities of daily living), Palliative care 
Outcome Score (POS)12 and Australian Karnofsky Performance Scale (AKPS) (a palliative 
modified version of the original scale.13 The carers (if present) completed the Care Strain 
Index and Carer Support Needs Assessment Tool (CSNAT).4 GPs completed a Likert scale 
about the acceptability of the NAT:PD-C in clinical practice. 
Statistical analysis 
Inter-rater reliability was assessed using unweighted and weighted Fleiss’ kappa statistics.. 
Disagreement weights were used with 0.0 for agreement, 1.0 for a difference of one category 
(0 vs. 1 or 1 vs. 2) and 2.0 for a difference of two categories (0 vs. 2).  Test-retest reliability 
was assessed using a kappa statistic was used to assess agreement and interpreted alongside 
percentage agreement.14 At least fair agreement was considered evidence of adequate 
reliability. Data simulations provided a sample size of 100 views to detect a kappa statistic of 
at least moderate to substantial agreement (within +/- 0.1, based on a 90% confidence level).   
For the construct validity testing of the NAT: PD-C, the NAT:PD-C and comparator scores 
are presented as n (%) and mean (sd) median (minimum, maximum).  Data simulations 
provided a sample size of 38 required to provide ≥93% power to detect a relationship 
between the NAT:PD-C and the physical symptoms domain of the Palliative care Outcome 
Scale (POS) (at least a value >0.3 [fair agreement]).  The assessment of correlation between 
the patient NAT:PD-C items (NAT:PD-C Section 2) and the patient-reported comparator 
tools was assessed using Kendall’s Tau-b correlation coefficients. This allows comparison 
between the NAT:PD-C items, which produce an ordinal score, with the tools: ESAS, RUG-
ADL and POS and the p-values are quoted. Cohen’s kappa was used to compare NAT:PD-C 
item 2.7 (information needs). To assess the relationship between the level of concern 
NAT:PD-C daily living item and both the total RUG-ADL score and the AKPS, Kruskall 
Wallis tests were used.  
The prevalence and bias adjusted kappa (PABAK), Cohen’s kappa and percentage of 
agreement were used to assess whether responses were similar between the NAT: PD-C items 
relating to the ability and wellbeing of the carer (NAT:PD-C Sections 3 and 4) and 
appropriate CSI and CSNAT items measuring similar concerns/support needs. For each 
NAT:PD-C item, the agreement between none or at least some concern was calculated. At 
least fair agreement for PABAK was considered evidence of adequate reliability.  
To assess the acceptability of the NAT:PD-C the n (%) for each category is presented.  
All analyses were undertaken on STATA/SE 14 (StataCorp LP) and a p-value of <0.05 was 
considered to indicate statistical significance. The paper followings the GRRAS checklist for 
reporting of studies of reliability and agreement.15 
Ethical approval from the NRES Committee London - Bloomsbury (REF:13/LO/1229) and 
intuitional permissions were obtained prior to data collection. 
  
Results 
Reliability assessment of the NAT: PD-C 
Fifty five GPs and seven nurses provided 121 tests (GPs: mean age 40.3 (10.0), women 29 
(53%); nurses: mean age 44.6 (13.1), 6 (86%) women.  Clinicians had 13.1 (9.5and 13.7 (6.7) 
mean years of experience respectively. Table 1 shows the inter-rater and test-retest reliability 
of the adapted tool.  
TABLE 1 HERE 
Inter-rater reliability 
There was at least fair reliability for all items in Section 2 in assessing patient wellbeing, with 
moderate inter-rater reliability for 2/6 items: daily activities (Kappa: 0.50) and psychological 
symptoms (Kappa: 0.46).   
In Section 3, assessing the ability of the carer/family to care for the patient, there was at least 
fair reliability for 4/5 items with moderate inter-rater reliability for the “difficulty coping” 
item (Kappa: 0.47). There was fair inter-rater reliability for carer/family wellbeing item of 
grief (Kappa: 0.21).. 
Test-retest reliability  
Twenty one GPs and six nurses undertook 46 re-tests. The mean time between viewings was 
32 (17.9) days. The results show at least moderate reliability for 5/6 patient wellbeing items 
and 5/5 for the ability of carer to care for patient. In the section assessing carer’s well-being 
there was substantial inter-rater reliability for the carer or family experiencing grief item 
(Kappa: 0.70). 
 
Construct validity testing 
Seventeen GPs (mean age 46.1years (10.7) years, range 28-63; 69% men) completed at least 
one NAT:PD-C assessment with a patient. Thirty-nine people with advanced cancer 
participated (mean age 74.0 years [SD: 13.6], range 20–93 years; 56% men).  Twenty-two 
carers (mean age 68.6 years (SD: 12.7), range 44–83; 38% men) completed at least one item 
of the comparator scales.  
Thirty-seven (95%) of patients had a carer available, 7 (18%) patients and/or carer had 
requested a referral to SPCS and 9 (23%)  clinicians stated that they required assistance in 
managing the care of the patients and/or family. The distribution of scores of the NAT: PD-C 
are shown in Table 2. The average total RUG-ADL score was 5.33 (2.26), 4 (4, 11) and the 
average score for AKPS was 64.9 (14.1), 60 (40, 90).  Descriptive summaries for patient-
reported questionnaires are shown in Table 3 and carer-report questionnaires in Table 4. and 
4.  
 
TABLE 2 HERE 
TABLE 3 HERE 
TABLE 4 HERE 
 
The mapping of each item in Section 2, assessing patient wellbeing, with the items from the 
patient-reported questionnaires that measure the same construct, are shown in Table 5. 
The NAT:PD-C has at least fair agreement (>0.3) for 5/6 the patient wellbeing domains. 
There was high moderate agreement for daily living and the RUG-ADL total score  (0.57, 
p<0.001).  The patient item “daily living” was positively correlated with the RUG-ADL total 
score . The mean RUG-ADL score for patients with no NAT:PD-C identified concerns with 
daily living ability was statistically significantly lower compared with scores of those with 
“some” or “significant” concerns (4.13 (0.52) vs 4.94 (1.91) vs 8.38 (2.33); p=0.044). The 
AKPS was significantly lower for participants with greater NAT-identified needs (p<0.001). 
TABLE 5 HERE 
The mapping of each item in Sections 3 and 4 of the NAT:PD-C, in assessing carer ability 
and wellbeing, with the items from the carer-reported questionnaires that measure the same 
construct are shown in Table 6.  The NAT:PD-C has adequate construct validity (5/8); 3/8 of 
the carer domains showing moderate agreement (providing physical care (PABAK: 0.59), 
coping with psychological problems (PABAK: 0.48) and carer experiencing unresolved 
psychosocial problems or feelings (PABAK: 0.50) and strong agreement 2/8 for information 
needs (PABAK: 0.69) and impending grief (PABAK: 0.65).  
 
TABLE 6 HERE 
 
Acceptability of the tool 
Over three-quarters (15 (88%)) agreed or strongly agreed that the NAT:PD-C  was acceptable 
to use within a UK primary care clinical setting and 2 (12%) were neutral.  
 
  
Discussion 
Main findings/results of the study 
The NAT:PD-C showed adequate inter-rater reliability and construct validity given the broad 
constructs assessed and the broad clinical experience represented. The strength of 
associations were similar to testing of the original NAT:PD-C and the versions adapted for 
heart failure and interstitial lung disease.16 
The constructs of patient-reported and other measures used as comparator tools are related 
but different to assessment of need, therefore it is not surprising that relatively few items 
rated as moderate or strong agreement. Similarly, some NAT:PD-C carer items overlap with 
concerns within CSI and CSNAT, but are not directly comparable. The original NAT-PD-C, 
with similar psychometric properties to those reported here, resulted in reduced patient and 
carer needs when applied in practice.17 This is the key factor in any clinical tool.  
The outcomes being measured are subjective and very broad in most categories. For example, 
“Is the patient experiencing unresolved physical symptoms?” covers a large range of issues 
more fully identified in the suggested areas of concern. This design is deliberately broad 
enough to capture as many concerns as possible, assessed in the context of a “screening” 
consultation so as to keep this as near daily clinical practice as possible. This is a strength in a 
clinical setting. It could be seen as a weakness for a standardised measurement tool as it does 
not have the exactness to give good Tau or kappa values across the board.   
The NAT:PD-C is therefore best seen as a communication and decision tool where action is 
thereby triggered if more in-depth exploration is needed, rather than an outcome 
measurement. Formulation of a clinical diagnosis is an inexact science with considerable 
variation between clinicians.18 For example, the Kappa value for clinician-agreement about 
the presence of individual respiratory signs reaches fair to moderate agreement only,19, 20 but 
are nevertheless considered as core clinical skills. Agreement about groups of symptoms and 
signs are even more difficult to standardise.18 
 
We deliberately included clinicians with a range of clinical experience to increase 
generalisability in daily practice. However, this brings further variation; one study of 
consultants and trainees conducting neurological examinations found senior neurologists 
inter-rater Kappa values ranged from 0.40 to 0.67 and from 0.22 to 0.81 for trainees.21 Some 
NAT:PD-C items with poor agreement may indicate clinicians’ lack of confidence in 
assessing this aspect of patient concern e.g. spiritual and existential concerns and may reflect 
an important area of clinician discomfort and/or educational need rather than a weakness in 
the tool.  
Inter-rater reliability was only fair for the item assessing carer distress about the patient’s 
physical symptoms. Carer reluctance to discuss these issues in great detail may have 
contributed to the results, since previous research has found that carers prefer to concentrate 
on the issues of the patient during consultations.4 
 
Strengths and weaknesses/limitations of the study 
Clinicians with a wide range of clinical experience were included to make this tool 
generalisable and the tool was assessed in a clinical primary care practice context. 
Paradoxically low values of kappa may occur when one of the categories is chosen by most 
observers for most participants.14 This was the case for items with lower weighted kappa 
statistics and the agreement level may be underestimated.  
There were relatively small numbers of carers and may have been insufficient to demonstrate 
agreement. 
The observational rather than participatory nature of the inter-rater video testing is likely to 
reduce the level of agreement as clinicians cannot “pick up the cue” and explore it in the 
consultation, limiting the clinician’s ability to refine their assessment. 
The clinician participants rated the videos after approximately 10 – 15 minutes training only. 
A learning effect is likely and clinicians using the tool in daily practice will have more 
experience with using the tool than participants.  
 
Next steps 
To successfully implement the NAT:PD-C in clinical practice attention must be given to 
practical implications of training needs, and organisation of services. Implementation work 
conducted alongside another adaptation of the NAT:PD-C for people with interstitial lung 
disease22 identified the need, in addition to the initial training of how to use the tool, to 
provide training in communication skills and symptom management.23 
There was stronger agreement for function than symptoms. Clinicians may be more likely to 
notice symptoms severe enough to cause disability. The poorer agreement for these items 
may therefore improve with training, and represent a lack of skills or confidence.  
The tool is yet to be tested in a clinical trial to evaluate its use by clinicians in terms of impact 
on patient and carer experience. Further work is also needed to determine the most effective 
way to use this tool in practice.  
Conclusion 
The adapted NAT:PD-C is reliable and valid in the UK primary care setting and may be a 
useful resource for identifying patient and carer concerns and triage those appropriate for 
referral to other care team members or specialist providers.  
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Table 1: Inter-rater reliability and test-retest results 
 Inter-rater reliability Test-retest 
Question Number of 
observations 
Distribution of categories 
 
 
 
Weighted 
kappa 
 
Number of 
observations 
Agreement Kappa P 
Section 1: Priority referral for further 
assessment 
 No Yes      
1.1 Does the patient have a carer readily 
available if required?   
95 17.9% 82.1% 
 
0.27 38 92% 0.75 <0.001 
1.2 Has the patient or carer requested a 
referral to a Specialist Palliative Care 
Service (SPCS)?  
82 82.9% 17.1% 
 
0.10 35 97% 0.89 <0.001 
1.3 Do you require assistance in managing 
the care of this patient and/or family?  
87 69.0% 31.0% 
 
0.29 30 77% 0.46 0.006 
Section 2: Patient wellbeing  None Some/ 
potential 
Significant      
2.1 Is the patient experiencing unresolved 
physical symptoms?  
120 5.8% 54.2% 40.0% 0.24 46 67% 0.42 0.002 
2.2 Does the patient have problems with 
daily living activities?  
119 22.7% 47.9% 29.4% 0.50 46 74% 0.58 <0.001 
2.3 Does the patient have psychological 
symptoms that are interfering with 
wellbeing or relationships?  
117 45.3% 51.0% 13.7% 0.46 45 62% 0.37 0.006 
2.4 Does the patient have concerns about 
spiritual or existential issues?  
109 69.7% 23.0% 7.3% 0.39 40 70% 0.40 <0.001 
2.5 Does the patient have financial or legal 
concerns that are causing distress or require 
assistance?  
108 86.1% 11.1% 2.8% 0.22 40 83% 0.46 0.001 
2.6 From the health delivery point of view, 
are there health beliefs, cultural or social 
factors involving the patient or family that 
are making care more complex?  
108 66.7% 29.6% 3.7% 0.23 42 79% 0.54 <0.001 
Section 3: Ability of carer to care for 
patient 
 None Some/ 
potential 
Significant      
3.1 Is the carer or family distressed about 
the patient’s physical symptoms?  
110 43.6% 34.6% 21.8% 0.38 40 68%  0.49 <0.001 
3.2 Is the carer or family having difficulty 
providing physical care?  
107 64.5% 27.1% 8.4% 0.29 41 73% 0.50 <0.001 
3.3 Is the carer or family having difficulty 
coping?  
106 51.9% 36.8% 11.3% 0.47 43 70% 0.49 <0.001 
3.4 Does the carer or family have financial 
or legal concerns that are causing distress or 
require assistance?  
100 87.0% 13.0% 0.0% 0.10 35 83% 0.41 0.004 
3.5 Is the family currently experiencing 
problems that are interfering with their 
functioning or inter-personal relationships, 
or is there a history of such problems?  
103 67.0% 25.2% 7.8% 0.30 38 74% 0.52 <0.001 
Section 4: Carer/family wellbeing  None Some/ 
potential 
Significant      
4.1 Is the carer or family experiencing 
physical, psychosocial or spiritual problems 
that are interfering with their wellbeing or 
functioning?  
97 54.6% 42.3% 3.1% 0.19 36 75% 0.50 0.001 
4.2 Is the carer or family experiencing grief 
over the impending or recent death of the 
patient that is interfering with their 
wellbeing or functioning?  
90 70.0% 27.8% 2.2% 0.21 31 87% 0.70 <0.001 
NB. In interpreting the kappa statistics: < 0.2 as indicating poor or slight agreement, between 
0.21 and 0.40 as fair agreement, between 0.41 and 0.60 as moderate agreement, and between 
0.61 and 0.80 as good or substantial agreement.  
 
 
Table 2: Summary of clinician responses to the NAT: PD-C (N-39) 
Section 2: Patient wellbeing 
None 
Some/ 
potential 
Significant Missing 
2.1: Is the patient experiencing unresolved physical 
symptoms? 
5 (13%) 24 (62%) 10 (26%) 0 (0%) 
2.2: Does the patient have problems with daily living 
activities? 
15 (38%) 16 (41%) 8 (21%) 0 (0%) 
2.3: Does the patient have psychological symptoms 
that are interfering with wellbeing or relationships? 
29 (74%) 8 (33%) 2 (8%) 0 (0%) 
2.4: Does the patient have concerns about spiritual or 
existential issues? 
32 (82%) 3 (8%) 1 (3%) 3 (8%) 
2.5: Does the patient have financial or legal concerns 
that are causing distress or require assistance? 
37 (95%) 2 (5%) 0 (0%) 0 (0%) 
2.6: From the health delivery point of view, are there 
health beliefs, cultural or social factors involving the 
patient or family that are making care more 
complex? 
33 (85%) 3 (8%) 1 (3%) 2 (5%) 
2.7: Does the patient require information about 
either: the prognosis, the cancer, treatment options, 
financial/Legal issues, medical/health/support 
services or social/emotional issues. 
10 (26%) 
Section 3: Ability of carer to care for patient 
None 
Some 
/potential 
Significant Missing 
3.1: Is the carer or family distressed about the 
patient’s physical symptoms? 
18 (46%) 20 (51%) 0 (0%) 1 (3%) 
3.2: Is the carer or family having difficulty providing 
physical care? 
32 (82%) 5 (13%) 0 (0%) 2 (5%) 
3.3: Is the carer or family having difficulty coping? 25 (64%) 12 (31%) 1 (3%) 1 (3%) 
3.4: Does the carer or family have financial or legal 
concerns that are causing distress or require 
assistance? 
34 (87%) 3 (8%) 0 (0%) 2 (5%) 
3.5: Is the family currently experiencing problems 
that are interfering with their functioning or inter-
personal relationships, or is there a history of such 
problems? 
33 (85%) 2 (5%) 1 (3%) 3 (8%) 
3.6: Does the carer require information about: the 
prognosis, the cancer, treatment options, 
financial/Legal issues, medical/health/support 
services and/or social/emotional issues. 
5 (13%) 
Section 4: Carer/family wellbeing 
None 
Some 
/potential 
Significant Missing 
4.1: Is the carer or family experiencing physical, 
psychosocial or spiritual problems that are 
interfering with their wellbeing or functioning? 
27 (69%) 10 (26%) 0 (0%) 2 (5%) 
4.2: Is the carer or family experiencing grief over the 
impending or recent death of the patient that is 
interfering with their wellbeing or functioning? 
27 (69%) 6 (15%) 0 (0%) 6 (12%) 
 
 
 
Table 3:  Summary of patient responses for Palliative care Outcome Score (POS) and 
Edmonton Symptom Assessment System (ESAS) 
 
Mean (SD), Median (Min, 
Max)  
OR N (%) 
Palliative care Outcome Score (POS)*  
1: Have you been affected by pain? 
Not at all, no effect  
Slightly - but not bothered to be rid of it 
Moderately - pain limits some activity 
Severely - activities or concentration markedly affected 
Overwhelmingly - unable to think of anything else 
Missing  
 
10 (26%) 
13 (33%) 
9 (23%) 
6 (15%) 
1 (3%) 
0 (0%) 
2: Have other symptoms seemed to be affecting how you feel? 
No, not at all  
Slightly 
Moderately 
Severely 
Overwhelmingly 
Missing 
 
15 (39%) 
13 (33%) 
8 (21%) 
2 (5%) 
1 (3%) 
0 (0%) 
3: Have you been feeling anxious or worried about your illness? 
No, not at all 
Occasionally 
Sometimes - affects my concentration now and then   
Most of the time - often affects my concentration     
Can’t think of anything else - completely pre-occupied by worry and 
anxiety 
Missing 
 
17 (44%) 
7 (18%) 
10 (26%) 
4 (10%) 
1 (3%) 
0 (0%) 
4: Have any of your family or friends been anxious or worried 
about you? 
No, not at all 
Occasionally 
Sometimes – it seems to affect their concentration  
Most of the time 
Yes, always preoccupied with worry about me 
Missing 
 
13 (33%) 
10 (26%) 
4 (10%) 
11 (28%) 
1 (3%) 
0 (0%) 
5: How much information have you and your family or friends 
been given? 
 
32 (82%) 
Full information or as much as wanted – always feel free to ask 
Information given but hard to understand 
Information given on request but would have liked more 
Very little given and some questions were avoided  
None at all – when we wanted information 
Missing 
1 (3%) 
3 (8%) 
0 (0%) 
3 (8%) 
0 (0%) 
6: Have you been able to share how you are feeling with your 
family or friends? 
Yes, as much as I wanted to 
Most of the time 
Sometimes 
Occasionally 
No, not at all with anyone 
Missing 
 
24 (62%) 
8 (20%) 
5 (13%) 
1 (3%) 
1 (3%) 
0 (0%) 
7: Have you felt that life was worthwhile? 
Yes, all the time 
Most of the time 
Sometimes 
Occasionally 
No, not at all 
Missing 
 
23 (59%) 
7 (18%) 
4 (10%) 
1 (3%) 
4 (10%) 
0 (0%) 
8: Have you felt good about yourself as a person? 
Yes, all the time 
Most of the time 
Sometimes 
Occasionally 
No, not at all 
Missing 
 
13 (33%) 
15 (39%) 
3 (8%) 
5 (13%) 
3 (8%) 
0 (0%) 
9: How much time do you feel has been wasted on appointments 
relating to your healthcare? 
None at all  
Up to half a day wasted   
More than half a day wasted  
 
32 (82%) 
6 (15%) 
1 (3%) 
0 (0%) 
Missing 
10: Have any practical matters resulting from your illness, 
either financial or personal 
Practical problems have been addressed and my affairs are as up to 
date as I would wish / I have had had no practical problems 
Practical problems are in the process of being addressed 
Practical problems exist which were not addressed 
Missing 
 
23 (59%) 
 
10 (26%) 
5 (13%) 
1 (3%) 
Edmonton Symptom Assessment System (ESAS)  
1: Pain 3.6 (3.0), 3 (0, 9) 
2: Tired 6.1 (2.4), 6 (2, 10) 
3: Nausea 0.8 (1.5), 0 (0 ,6) 
4: Depression 2.2 (2.9), 0 (0, 10) 
5: Anxiety 3.3 (3.0), 3 (0, 8) 
6: Drowsy 4.4 (3.2), 5 (0, 10) 
7: Appetite 2.7 (3.3),1 (0, 10) 
8: Wellbeing 5.1 (2.8), 5 (0, 10) 
9: Shortness of breath 4.8 (3.2), 5 (0, 10) 
10: Other problem 3.8 (3.7)/ 3 (0, 10) 
* % may not sum to 100% due to rounding 
 
 
Table 4: Summary of responses to the Carer Strain Index and Carer Support Needs 
Assessment Tool 
Carer Strain Index (CSI)* No Yes Missing 
1: Sleep is disturbed 10 (46%) 12 (54%) 0 (0%) 
2: It is inconvenient 18 (82% 4 (18%) 0 (0%) 
3: It is a physical strain 18 (82%) 4 (18%) 0 (0%) 
4: It is confining 10 (46%) 12 (54%) 0 (0%) 
5: There have been family adjustments 15 (68%) 7 (32%) 0 (0%) 
6: There have been changes in personal 
plans 
15 (68%) 7 (32%) 0 (0%) 
7: There have been changes in other 
demands on time 
20 (91%) 2 (9%) 0 (0%) 
8: There have been emotional adjustments 17 (77%) 5 (23%) 0 (0%) 
9: Some behaviour is upsetting 13 (59%) 9 (41%) 0 (0%) 
10: It is upsetting to find…has changed 
much from his/her former self 
14 (64%) 8 (36%) 0 (0%) 
11: There have been work adjustments 18 (82%) 4 (18%) 0 (0%) 
12: It is a financial strain 18 (82%) 4 (18%) 0 (0%) 
13: Feeling completely overwhelmed 15 (68%) 6 (27%) 1 (5%) 
Carer Support Needs Assessment Tool 
(CSNAT)* 
“Do you need more support with…” 
No A little more 
Quite a bit 
more 
Very much 
more 
Missing 
1: Understanding your relative's illness 13 (59%) 7 (32%) 1 (5%) 1 (5%) 0 (0%) 
2: Having time for yourself in the day 14 (64%) 8 (36%) 0 (0%) 0 (0%) 0 (0%) 
3: Managing your relative’s symptoms,  
including giving medicines 
20 (91%) 0 (0%) 1 (5%) 0 (0%) 1 (5%) 
4: Your financial, legal or work issues 20 (91%) 2 (9%) 0 (0%) 0 (0%) 0 (0%) 
5: Providing personal care for your 
relative 
18 (82%) 3 (14%) 0 (0%) 1 (5%) 0 (0%) 
6: Dealing with your feelings and worries 16 (73%) 4 (18%) 1 (5%) 1 (5%) 0 (0%) 
7: Knowing who to contact if you are 
concerned about your relative 
19 (86%) 1 (5%) 2 (9%) 0 (0%) 0 (0%) 
8: Looking after your own health 18 (82%) 3 (14%) 1 (5%) 0 (0%) 0 (0%) 
9: Equipment to help care for your relative 17 (77%) 5 (23%) 0 (0%) 0 (0%) 0 (0%) 
10: Your beliefs or spiritual concerns 19 (86%) 2 (9%) 0 (0%) 1 (5%) 0 (0%) 
11: Talking with your relative about his or 
her illness 
18 (82%) 3 (14%) 1 (5%) 0 (0%) 0 (0%) 
12: Practical help in the home 16 (73%) 4 (18%) 1 (5%) 0 (0%) 1 (5%) 
13: Knowing what to expect in the future 
when caring for your relative 
12 (54%) 7 (32%) 3 (14%) 0 (0%) 0 (0%) 
14: Getting a break from caring overnight 19 (86%) 2 (9%) 1 (5%) 0 (0%) 0 (0%) 
15: Anything else 15 (68%) 0 (0%) 0 (0%) 0 (0%) 7 (32%) 
* % may not sum to 100% due to rounding 
 
 
Table 5: Mapping of each tool with of responses to the NAT: PD-C;  Section 2: Patient 
wellbeing and construct validity. 
Concept measured Corresponding NAT items: 
(levels of concern 0, 1, 2) 
Comparator tool Kendall’s Tau-b 
correlation coefficient 
OR Kappa, (p-value) 
and n 
Physical Symptoms  2.1: Is the patient experiencing 
unresolved physical symptoms? 
Edmonton Symptom Assessment Scale: Combination 
of items 1: pain, 3: nausea, 6: drowsiness, 7: appetite 
and 9: shortness of breath. 
0.30 (p=0.027), n=38 
Concept measured Corresponding NAT items: 
(levels of concern 0, 1, 2) 
Comparator tool Kendall’s Tau-b 
correlation coefficient 
OR Kappa, (p-value) 
and n 
POS: Combination of POS1: have you been affected 
by pain? and POS2: have other symptoms seemed to 
be affecting how you feel? 
0.13 (p=0.353), n=39 
Physical functioning 2.2: Does the patient have 
problems with daily living 
activities? 
RUG-ADL total score 
AKPS 
0.57 (p<0.001), n=39 
0.30 (p=0.030), n=39 
Psychological symptoms   2.3: Does the patient have 
psychological symptoms that are 
interfering with wellbeing or 
relationships? 
Edmonton Symptom Assessment Scale:  
Combination of items 4: depression, 5: anxiety and 8: 
feeling of wellbeing. 
0.30 (p=0.025), n=39 
POS: Combination of POS3: feeling anxious or 
worried about your illness?, POS7: have you felt that 
life was worthwhile? and POS 8: have you felt good 
about yourself as a person? 
0.35 (p=0.012), n=39 
Psycho-spiritual 
symptoms 
2.4: Does the patient have 
concerns about spiritual or 
existential issues? 
POS: Combination of POS3: feeling anxious or 
worried about your illness?, POS7: have you felt that 
life was worthwhile? and POS 8: have you felt good 
about yourself as a person? 
0.38 (p=0.009), n=36 
Psycho-social functioning 2.5: Does the patient have 
financial or legal concerns that 
are causing distress or require 
assistance? 
POS 10: Have any practical matters resulting from 
your illness, either financial or personal 
0.21 (p=0.177), n=38 
2.6: From the health delivery 
point of view, are there health 
beliefs, cultural or social factors 
involving the patient or family 
that are making care more 
complex? 
POS: Combination of POS 4: have any of your 
family or friends been anxious or worried about you? 
and POS6: have you been able to share how you are 
feeling with your family or friends? 
0.03 (p=0.842), n=37 
Information requirements 2.7: Does the patient require 
information about either: the 
POS 5: How much information have you and your 
family or friends been given? 
Kappa=0.18 (p=0.249), 
n=39 
Concept measured Corresponding NAT items: 
(levels of concern 0, 1, 2) 
Comparator tool Kendall’s Tau-b 
correlation coefficient 
OR Kappa, (p-value) 
and n 
prognosis, the cancer, treatment 
options, financial/Legal issues, 
medical/health/support services 
or social/emotional issues. 
 
NB. For this analysis, the three levels of concern in the NAT:PD-C were grouped into 
0=‘None’ versus 1=‘Some/potential’ + ‘Significant’; the CSI responses were coded 0 for 
‘No’ and 1 for ‘Yes’; and the four CSNAT item responses were categorised into two groups  
(0=‘No’ versus 1=‘A little more’ + ‘Quite a bit more’ + ‘Very much more’).   
 
 
Table 6: Mapping of each tool with of responses to the NAT: PD-C Section 3: ability of 
carer or family to care for the patient and Section 4: Carer/family wellbeing 
Corresponding NAT items:  
(levels of concern 0, 1, 2) 
Comparator items from CSI and CSNAT 
(sum of scores for items listed) or POS 
question. 
Kendall’s Tau-b 
correlation coefficient 
OR Kappa, p-value and 
n 
PABAK % Agreed 
Section 3: Ability of carer to care for patient 
3.1: Is the carer or family 
distressed about the patient’s 
physical symptoms? 
CSI9: Some behaviour is upsetting, CSI13: 
Feeling completely overwhelmed and CSNAT3: 
Managing your relative’s symptoms, including 
giving medicines 
Kappa=0.11, p=0.960, 
n=19 
0.21 47% 
3.2: Is the carer or family 
having difficulty providing 
physical care? 
CSI3: It is a physical strain, CSI13: Feeling 
completely overwhelmed, CSNAT3: Managing 
your relative’s symptoms, including giving 
medicines, CSNAT5: Providing personal care 
for your relative, CSNAT9: Equipment to help 
Kappa=0.37, p=0.093, 
n=19 
0.59 72% 
care for your relative and CSNAT12: Practical 
help in the home 
3.3: Is the carer or family 
having difficulty coping? 
CSI8: There have been emotional adjustments, 
CSI9: Some behaviour is upsetting and CSI13: 
Feeling completely overwhelmed 
 
POS 4: Over the last 3 days, have any of your 
family or friends been anxious or worried about 
you? 
Kappa=0.31, p=0.142, 
n=20 
 
 
Kendall’s Tau-b 
correlation coefficient = 
0.21, (p=0.152) n=38 
0.48 65% 
3.4: Does the carer or family 
have financial or legal 
concerns that are causing 
distress or require assistance? 
CSI11: It is a financial strain and CSNAT4: 
Your financial, legal or work issues 
Kappa=0.10, p=0.147, 
n=21 
0.07 29% 
3.5: Is the family currently 
experiencing problems that are 
interfering with their 
functioning or inter-personal 
relationships, or is there a 
history of such problems? 
CSI4: It is confining, CSI5: There have been 
family adjustments, CSI6: There have been 
changes in personal plans, CSI7: There have 
been emotional adjustments, CSI9: It is upsetting 
to find…has changed so much from his/her 
former self, CSI10: There have been work 
adjustments, CSNAT2: Having time for yourself 
in the day and CSNAT11: Talking with your 
relative about his or her Illness. 
Kappa=0.02, p=0.619, 
n=21 
0.14 24% 
3.6: Does the carer require 
information about: the 
prognosis, the cancer, 
treatment options, 
financial/Legal issues, 
medical/health/support services 
or social/emotional issues. 
POS 5: Over the last 3 days, how much 
information have you and your family or friends 
been given? 
Kappa=0.22, p=0.169 0.69 75% 
Section 4: Carer/family wellbeing 
4.1: Is the carer or family 
experiencing physical, 
psychosocial or spiritual 
CSI1: Sleep is disturbed , CSI2: It is 
inconvenient, CSI7: There have been emotional 
adjustments, CSI13: Feeling completely 
Kappa=0.23, p=0.216, 
n=19 
0.37 58% 
problems that are interfering 
with their wellbeing or 
functioning? 
overwhelmed, CSNAT6: Dealing with your 
feelings and worries, CSNAT8: Looking after 
your own health, CSNAT10: Your beliefs or 
spiritual concerns and CSNAT14: Getting a 
break from caring overnight 
4.2: Is the carer or family 
experiencing grief over the 
impending or recent death of 
the patient that is interfering 
with their wellbeing or 
functioning? 
CSNAT13: Knowing what to expect in the future 
when caring for your relative 
Kappa=0.39, p=0.041, 
n=17 
0.65 76% 
 
 
 
 
 
